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Sophisticated regulation of the actin cytoskeleton by a variety of actin-binding proteins is essential for eukaryotic cells to perform
their diverse functions. The plastin (also know, as ﬁmbrin) protein family belongs to actin-bundling proteins, and the protein
family is evolutionarily conserved and expressed in yeast, plant, and animal cells. Plastins are characterized by EF-hand Ca2+-
binding domains and actin-binding domains and can cross-link actin ﬁlaments into higher-order assemblies like bundles. Three
isoforms have been identiﬁed in mammals. T-plastin is expressed in cells from solid tissues, such as neurons in the brain. I-plastin
expression is restricted to intestine and kidney; the isoform plays a vital role in the function of absorptive epithelia in these organs.
L-plastin is expressed in hematopoietic cell lineages and in many types of cancer cells; the isoform is thus considered to be a useful
biomarker for cancer.
1.Introduction
Dynamics of the actin cytoskeleton is one of the cardinal
features of eukaryotic cells, which is essential for funda-
mental cellular functions such as cell division, intracellular
traﬃc of organelles, cell morphology, and cell motility [1].
The architecture of the actin cytoskeleton is regulated by a
variety of proteins termed actin-binding proteins [1]. Actin
ﬁlaments are organized into two types of arrays: bundles
and weblike networks. Likewise, the actin ﬁlaments cross-
linking proteins that help to stabilize and maintain these
distinct structures are divided into two classes: bundling
proteins and web-forming proteins. The plastin (also known
as ﬁmbrin) protein family belongs to bundling proteins and
isevolutionarilyconservedfromyeasttomammaliancells.In
mammals,threeisoformsareknowntobeexpressedinacell-
type-speciﬁc manner and exhibit distinct properties (Table 1
and Figure 1). In this paper, studies regarding the structure
and biological functions of plastins are reviewed.
2. Structureof Plastins
The structure of plastins is well conserved from lower
eukaryotes to humans and is characterized by actin binding
domains (ABD). An ABD consists of a pair of ∼125
residue calponin-homology (CH) domains (Figure 2(a)).
ABD-containing proteins include proteins such as spectrin,
α-actinin, dystrophin, cortexillin, and plastin/ﬁmbrin [2].
The plastins are unique among these, as they possess two
tandem repeats of ABD (ABD1 and ABD2) within a single
polypeptide chain and cross-link actin ﬁlaments into higher
order assemblies like bundles through this tandem pair
of ABDs [3]. N-terminal EF-hand Ca2+-binding domains
(Figure 2(a)) are also important, since the actin bundling
activity of plastins is regulated by Ca2+ [4].
Though ABD1 was previously solved by X-ray crystal-
lography [5], the complete crystal structure of plastins has
not yet been resolved. We have recently performed confor-
mational analyses of murine L-plastin by X-ray scattering in
solution and for the ﬁrst time shown the overall structure of
full-length plastin protein by reconstructing from data using
the DAMMIN program (Figure 2(b))[ 6]. The program
DAMMIN is an advanced modeling procedure designed to
reconstruct the shape of a molecule from the scattering
intensity of small angle X-ray scattering data. Our results,
taken together with those by Klein et al. on the plastin core
region [7], demonstrated that plastin has a compact globular
structure rather than a dumbbell-like shape and that the two2 International Journal of Cell Biology
Table 1: Plastin isoforms expressed in distinct cell types.
Isoforms Cell/tissue types
I-plastin (Plastin 1) Intestine and kidney
L-plastin (Plastin 2) Leukocytes and cancer
T-plastin (Plastin 3) Solid tissues
Mouse Human
I-plastin (Plastin 1)
94%
96%
99%
73% 73%
L-plastin (Plastin 2) 75% 75%
79% 79%
T-plastin (Plastin 3)
I-plastin (Plastin 1)
L-plastin (Plastin 2)
T-plastin (Plastin 3)
Figure 1: Human and mouse plastin isoforms. The homology bet-
ween the amino acid sequences of these isoforms is showed.
ABDs are packed together in an approximately antiparallel
arrangement with the N- and C-terminal CH domains (CH1
and CH4) making direct contact (Figure 2(c)). We also
demonstrated that signiﬁcant conformational changes of the
protein were induced in the presence of Ca2+ [6]. These
ﬁndings should shed light on the molecular mechanisms of
how plastins regulate the architecture of actin ﬁlaments.
3. Functions of Plastin Isoforms
Since plastins are expressed in a cell-type-speciﬁc manner,
it is conceivable that the most suitable isoform is expressed
t or e g u l a t et h ea c t i nc y t o s k e l e t o ni nap a r t i c u l a rt y p eo fc e l l .
Functions of plastin isoforms in distinct types of cells or
tissues in mammals are reviewed.
3.1. Plastin Functions in Leukocytes. We isolated a 65-
kDa cytosolic protein that was phosphorylated in murine
macrophages by stimulation with bacterial lipopolysaccha-
ride (LPS) and determined its complete primary structure
as a novel protein [8–10]. The sequence of the 65-kDa
protein revealed that it was a murine homolog of human
L-plastin that had been identiﬁed as a transformation-
induced polypeptide of neoplastic human ﬁbroblasts [11].
We further demonstrated that L-plastin plays an important
role in macrophage functions such as host defense against
bacterial infections [12–15]. We, and others, have clariﬁed
that L-plastin is exclusively expressed in leukocytes such as
lymphocytes, macrophages, and granulocytes under phys-
iological conditions. Representative studies addressing the
role of L-plastin in leukocyte functions are shown in Table 2
[8–10, 12–39]; the isoform serves important functions not
only in cells of innate immunity such as macrophages and
N C CH1 CH2 CH3 CH4
E
F
E
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Figure 2: Schematic diagram of L-plastin structure. (a) Domain
organization of L-plastin. The protein possesses an N-terminal
headpiece of ∼100 amino acids containing two EF-hand Ca2+-
binding motifs and two actin-binding domains (ABDs) consist-
ing of ABD1 (residues 120–379) and ABD2 (residues 394–623),
and each ABD contains two calponin-homology (CH) domains.
(b) Reconstructed molecular shape of L-plastin. Conformational
analyses of L-plastin by X-ray scattering in solution revealed that
plastin has a compact globular structure rather than a dumbbell-
like shape. It is conceivable that the two ABDs are packed together
in an approximately antiparallel arrangement with the N- and C-
terminal CH domains (CH1 and CH4) making direct contact as
shown in Figure 2(c);t h a ti s ,X, Y,a n dZ correspond to CH1–CH3,
CH2–CH4, and CH3-CH4 of the plastin protein, respectively. P
indicatesaputativeN-terminalheadpiece.Seemoredetailsin[6,7].
(c) Possible arrangement of the ABDs (CH1–CH4) of L-plastin in
solution without Ca2+.
granulocytes (neutrophils and eosinophils) [8–10, 12–29],
but also in those of adaptive immunity such as T and B
lymphocytes [30–37].
Many of the studies have addressed the phosphorylation
of L-plastin during leukocyte activation by various stimuli
(Table 2). Only L-plastin has, so far, been known to be phos-
phorylated in cells among three isoforms. We demonstrated
that L-plastin was phosphorylated exclusively on Ser5 inInternational Journal of Cell Biology 3
Table 2: Studies on L-plastin in leukocytes.
Leukocyte types Key words of the study References
Innate immunity
Macrophages Bacterial lipopolysaccharide (LPS)-induced activation [8–10, 12]∗,[ 13, 14]
Macrophages Grancalcin and host defence [15]
Macrophages IL-1/TNF-induced activation [16]∗
Macrophages Podosome formation [17]
Macrophages Zebraﬁsh and lineage marker [18–20]
Macrophages Toxoplasma gondii-infection [21]
Neutrophils IL-8-induced activation [22]∗
Neutrophils Fc receptor and phagocytosis [23, 24]∗
Neutrophils L-plastin KO# and integrin [25, 26]∗
Eosinophils GM-CSF-induced priming [27]∗
Osteoclasts Podosome formation [28]
Osteoclasts Sealing ring formation [29]
Adaptive immunity
T-cells IL-2-induced activation [30]∗
T-cells Accessory receptors [31]∗
T-cells Lymphokine-activated killer cells [32]∗
T-cells Costimulation [33]∗
T-cells CCR7 and thymus [34]
T-cells LFA-1 and immune synapse [35]
T-cells L-plastin KO# and impaired T cell responses [36]
B-cells Marginal zone B cell development [37]
Suppression immunotherapies targeting L-plastin
Leukocytes Cannabinoid receptor agonists [38]
Leukocytes Glucocorticoid dexamethasone [39]
∗These studies addressed the L-plastin phosphorylation in leukocytes.
#Disruption of the L-plastin gene in mice.
macrophages by stimulation with LPS [10]. In connection
withthis,Jonesetal.showedthattheSer5-phosphorylatedL-
plastin peptide induced adhesion in neutrophils [25]. It was
also demonstrated that phosphorylation on Ser5 increased
the F-actin-binding activity of L-plastin and promoted
its targeting to sites of actin assembly in cells [40]. In
addition to phosphorylation, the actin-bundling action of
L-plastin is also regulated by intracellular Ca2+ [4]. The
above ﬁndings indicate that L-plastin regulates the actin
cytoskeleton in a phosphorylation- and/or Ca2+-dependent
manner. These features of L-plastin seem to help leukocytes
rapidly rearrange their actin cytoskeleton when they need
to quickly respond to a variety of extracellular stimuli.
Indeed, it has recently been demonstrated by using L-plastin
gene-disrupted mice that neutrophils lacking L-plastin are
deﬁcient in killing bacterial pathogens [26] and that T and B
cell functions are also impaired in the mice; T cell responses
to antigens are impaired [36], and splenic maturation of B
cells and an antibody response to Streptococcus pneumoniae
are largely diminished [37].
These studies regarding the key roles of L-plastin in
leukocytes functions may provide the basis for new therapy.
Several suppression immunotherapies targeting L-plastin
have been proposed (Table 2)[ 38, 39]. Cannabinoid CB2
receptor-speciﬁc compounds were found to inhibit the L-
plastin phosphorylation in human monocytes and blocked
experimental autoimmune encephalomyelitis in the rat [38].
In addition, it has recently been shown that glucocorticoid
dexamethasone inhibits the L-plastin phosphorylation in
human T cells, which prevents the immune synapse forma-
tion and subsequent T cell activation [39].
3.2.PlastinFunctionsinNeurons. Thenervoussystemchieﬂy
expresses T-plastin among the three isoforms. Though
microglia in the brain are a kind of resident macrophage,
their expression of L-plastin is very low under physiological
conditions (unpublished observations). With regard to T-
plastin in neurons, an interesting article has recently been
published; the authors showed that high expression of T-
plastin acts as a protective modiﬁer of spinal muscular
atrophy (SMA), the most frequent genetic cause of early
childhood lethality, and that T-plastin is important for
axonogenesis, as its overexpression rescues the axon length
and outgrowth defects in neurons of the SMA mouse [41].
Therefore, T-plastin seems to play a vital role in neuronal
diﬀerentiation. Another interesting study addressed the4 International Journal of Cell Biology
preventive role of T-plastin in neurodegenerative diseases,
demonstrating that T-plastin lessens the toxicity of polyglu-
tamine proteins in neurons, such as ataxin and huntingtin,
that cause neurodegenerative disorder [42]. These, and
related studies, are summarized in Table 3 [41–43].
Since sensory cells are closely related to the nervous
system, studies regarding the plastin expression in sensory
cells are reviewed here as shown in Table 3. Several studies
using speciﬁc antibodies against plastins/ﬁmbrin revealed
that the proteins are expressed in the stereocilia of auditory
hair cells in the chicken and mammals [44–47], suggesting
that plastins may contribute to the physiological auditory
sense. In the rat cochlear hair cells, T- and I-plastin, but
not L-plastin, were found to be expressed [47]. T-plastin is
expressed only in the early stage of hair cell diﬀerentiation,
while I-plastin is constantly expressed from the early to the
adult stages, indicating that I-plastin is the major isoform
expressed in the adult cochlear hair cells. The architecture of
actin ﬁlaments cross-linked by plastins may be essential for
the transduction of auditory signals by cochlear hair cells.
3.3. Plastin Functions in the Intestine. The ﬁrst protein of
the plastin/ﬁmbrin family was discovered in microvilli of
the chicken intestinal brush border and named ﬁmbrin
[48]. Chicken ﬁmbrin was characterized as a cytoskeletal
protein that binds and cross-links F-actin ﬁlaments [49, 50].
Meanwhile, a third plastin isoform, named I-plastin, was
identiﬁed in humans and was found to be expressed in the
small intestine, colon, and kidney [51]. Thus, I-plastin is
considered to be the human homolog of chicken ﬁmbrin.
Using I-plastin gene-disrupted mice, it has recently been
reported that a lack of I-plastin results in increased fragility
of the intestinal epithelium and decreased transepithelial
resistance [52], suggesting that I-plastin is an important
regulatorofbrushbordermorphologyandstability.Recently,
a model of the microvillar cytoskeleton of the brush border
that includes plastin/ﬁmbrin cross-linking actin ﬁlaments
has been proposed [53]. These studies are summarized in
Table 4 [48–53].
3.4. Plastin Functions in Cancer. The cell-type-speciﬁc ex-
pression of plastin isoforms is strictly regulated under
physiological conditions. However, ectopic expression of
plastins in malignant cells has been observed in many studies
as shown in Table 5 [11, 54–69]. L-plastin that is normally
expressed only in hematopoietic cells is especially expressed
in a variety of cancer cells of nonhematopoietic origin.
Lin et al. demonstrated that 68% of cancers derived from
epithelia express L-plastin [54]. It was further clariﬁed by
using sensitive RT-PCR that the L-plastin gene is activated
in most human cancer cells [56]. Thus, L-plastin has been
considered to be a common marker of many types of
human cancer. In particular, a high percentage of cancer
cells arising from female reproductive tissues express L-
plastin constitutively and abundantly though its expression
is ovarian steroid hormone-independent in cancer cells [58].
In addition, the expression of L-plastin in prostatic epithelial
cells is linked to the malignant state, and once expressed in
Table 3:Studiesonplastinsinthenervoussystemandsensorycells.
Key words of the study References
T - p l a s t i ni nn e u r o n s
Spinal muscular atrophy and axonogenesis [41, 43]
Spinocerebellar ataxia and polyglutamine protein [42]
Plastin/ﬁmbrin in sensory cells
Fimbrin, chicken, stereocilia, auditory hair cells [44, 45]
I-plastin, mouse/rat, auditory hair cells [46, 47]
Table 4: Studies on ﬁmbrin/I-plastin in the intestine.
Key words of the study References
Fimbrin, Microvilli [48]
Intestinal brush border [49, 50]
I-plastin, Intestine, Kidney [51]
I-plastin KO#, Intestinal epithelium [52]
Model of microvillar cytoskeleton [53]
#Disruption of the I-plastin gene in mice.
carcinoma, its expression is regulated by steroid hormone
receptors [59]. The L-plastin gene promoter was found to
include several hormone receptor-responsive elements [55,
57]. These evidences support a trans-activation mechanism
for the activation of L-plastin synthesis accompanying
tumorigenesis. In contrast, T-plastin gene expression was
found to be suppressed in human colorectal cancer cells,
suggesting that downregulation of T-plastin is involved in
cancer development [65].
Since L-plastin is normally expressed in leukocytes that
are able to move rapidly to infectious and inﬂammatory
sites, cancer cells may gain the ability to metastasize to other
parts of the body by expressing L-plastin. In other words, L-
plastin tends to be expressed in freely movable cells such as
leukocytes and cancer cells. On the other hand, it was found
that T-plastin is expressed in certain types of malignant cells
of leukocyte origin, including cutaneous T cell lymphoma
and Sezary syndrome (Table 5)[ 66–69]. In cutaneous T cell
lymphoma, dense clusters or nodules of malignant cells are
observed [70]; these cells appear to lose their motility. This
seems to contrast sharply with the case of cancer cells that
express L-plastin. Considering the above, the expression of
plastin isoforms could be dysregulated when cells, regardless
of their origin, become malignant, which may endow tumor
cells with properties distinct from those of their normal
counterparts.
On the basis of these observations regarding abnormal
expression of plastins, clinical applications have been devel-
oped. Cancer screening and diagnosis methods assessing the
expression of plastins as a biomarker have been described.
These include choroids plexus tumors, urinary bladder
cancer, ovarian cancer, and colorectal cancer (Table 5)[ 71–
74]. Furthermore, gene therapy experiments targeting the
L-plastin gene or L-plastin promoters in cancer cells have
been started, as shown in Table 5 [75–78]. These approaches
have shown promising results. For example, Peng et al.International Journal of Cell Biology 5
Table 5: Studies on plastins in cancer cells.
Key words of the study References
Ectopic expression of L-plastin in cancer
Transformed human ﬁbroblasts [11]
Many types of human cancer [54]
L - p l a s t i ng e n ep r o m o t e ri nc a n c e r [ 55–57]
Ovarian steroid hormones [58]
Prostate cancer and steroid hormone [59]
Chromosome translocation [60]
Breast cancer and expression pattern [61]
Colorectal cancer and metastasis [62]
Colon cancer, invasion, and loss of E-cadherin [63]
Melanoma tumor invasion [64]
T-plastin downregulation and CpG methylation [65]
Ectopic expression of T-plastin in lymphoma
Cutaneous T cell lymphoma [66, 67]
Sezary cells [68, 69]
As a biomarker for cancer screening and diagnosis
Choroid plexus tumors and diagnostic marker [71]
B l a d d e rc a n c e ra n db i o m a r k e r [ 72]
Proteomics imaging and mass spectrometry [73]
Colorectal cancer and human feces [74]
Gene therapies targeting L-plastin gene
L-plastin promoter and gene therapy [75–77]
Antisense L-plastin gene and tumor suppression [78]
prepared adenoviral vectors in which a truncated human
L-plastin promoter and the cytosine deaminase (CD)g e n e
were coinserted [76]. CD is a bacterial gene which converts
5-ﬂuorocytosine (5FC: nontoxic to cells) to 5-ﬂuorouracil
(5FU: toxic to most cells). When the vector is transfected
into human ovarian or bladder cancer cells in vitro,C D
transcription is increased through the L-plastin promoter
activation, leading to tumor cell death via the conversion
of 5FC to 5FU in the cells. The authors also performed
in vivo study and demonstrated that human tumor masses
g r o w ni nn u d em i c ew e r er e d u c e db yt h i sm e t h o d[ 76].
In another study by Zheng et al., the authors constructed
retroviral vectors to express regions of the human L-plastin
gene in antisense orientation and found that introduction
of the vectors into prostate carcinoma cells reduced the
growth rates of the cells and suppressed their invasion and
motility in vitro [78]. This suggests that overexpression of
L-plastin is involved in cancer invasion and metastasis and
that downregulation of L-plastin by antisense delivery is
potentiallyausefulapproachtointerferewithprostatecancer
progression.
4.Perspectives
Since plastins are evolutionarily conserved and expressed in
yeast,plant,andanimalcells,theyshouldplayafundamental
role in cellular activities. Sophisticated regulation of the
actin cytoskeleton seems to be a mandatory event for the
functions of eukaryotic cells. It has been investigated in
detail how plastins interact with actin ﬁlaments in vitro.
Extensive studies have clariﬁed that three plastin isoforms
are expressed in distinct types of cells in mammals and that
dysregulated expression of plastins appears to be important
in the progression of various cancers. As described in this
paper, plastins can serve as versatile regulators of the actin
cytoskeleton in many aspects of cellular functions. Further
studies will be expected to reveal how plastins, together
with other actin-binding proteins, dynamically regulate
the remodeling of cytoskeletal architecture during diverse
cellular activities.
Abbreviations
ABD: Actin binding domain
CH: Calponin-homology
IL: Interleukin
LPS: Bacterial lipopolysaccharide
SMA: Spinal muscular atrophy
TNF: Tumor necrosis factor.
Acknowledgment
This work was supported by Grant-in-Aid for Scientiﬁc
Research (C). No conﬂict of interests is present.
References
[1] T. D. Pollard and J. A. Cooper, “Actin, a central player in cell
shape and movement,” Science, vol. 326, no. 5957, pp. 1208–
1212, 2009.
[2] S. Ba˜ nuelos, M. Saraste, and K. D. Carugo, “Structural
comparisons of calponin homology domains: implications for
actin binding,” Structure, vol. 6, no. 11, pp. 1419–1431, 1998.
[3] M. V. de Arruda, S. Watson, C. S. Lin, J. Leavitt, and P.
Matsudaira, “Fimbrin is a homologue of the cytoplasmic
phosphoprotein plastin and has domains homologous with
calmodulin and actin gelation proteins,” Journal of Cell
Biology, vol. 111, no. 3, pp. 1069–1079, 1990.
[4] Y. Namba, M. Ito, Y. Zu, K. Shigesada, and K. Maruyama,
“Human T cell L-plastin bundles actin ﬁlaments in a calcium
dependent manner,” Journal of Biochemistry, vol. 112, no. 4,
pp. 503–507, 1992.
[5] S. C. Goldsmith, N. Pokala, W. Shen, A. A. Fedorov, P.
Matsudaira, and S. C. Almo, “The structure of an actin-
crosslinking domain from human ﬁmbrin,” Nature Structural
Biology, vol. 4, no. 9, pp. 708–712, 1997.
[6] H. Shinomiya, M. Shinjo, L. Fengzhi, Y. Asano, and H.
Kihara,“Conformationalanalysisoftheleukocyte-speciﬁcEF-
hand protein p65/L-plastin by X-ray scattering in solution,”
Biophysical Chemistry, vol. 131, no. 1–3, pp. 36–42, 2007.
[7] M. G. Klein, W. Shi, U. Ramagopal et al., “Structure of the
actin crosslinking core of ﬁmbrin,” Structure, vol. 12, no. 6,
pp. 999–1013, 2004.
[8] H. Shinomiya, H. Hirata, and M. Nakano, “Puriﬁcation
and characterization of the 65-kDa protein phosphory-
lated in murine macrophages by stimulation with bacterial
lipopolysaccharide,” Journal of Immunology, vol. 146, no. 10,
pp. 3617–3625, 1991.6 International Journal of Cell Biology
[9] H. Shinomiya, H. Hirata, S. Saito, H. Yagisawa, and M.
Nakano, “Identiﬁcation of the 65-kDa phosphoprotein in
murine macrophages as a novel protein: homology with
human L-plastin,” Biochemical and Biophysical Research Com-
munications, vol. 202, no. 3, pp. 1631–1638, 1994.
[10] H. Shinomiya, A. Hagi, M. Fukuzumi, M. Mizobuchi, H.
Hirata, and S. Utsumi, “Complete primary structure and
phosphorylation site of the 65-kDa macrophage protein phos-
phorylated by stimulation with bacterial lipopolysaccharide,”
Journal of Immunology, vol. 154, no. 7, pp. 3471–3478, 1995.
[11] C. S. Lin, R. H. Aebersold, S. B. Kent, M. Varma, and J.
Leavitt, “Molecular cloning and characterization of plastin,
a human leukocyte protein expressed in transformed human
ﬁbroblasts,” Molecular and Cellular Biology, vol. 8, no. 11, pp.
4659–4668, 1988.
[12] A. Hagi, H. Hirata, and H. Shinomiya, “Analysis of a
bacterial lipopolysaccharide-activated serine kinase that phos-
phorylates p65/L-plastin in macrophages,” Microbiology and
Immunology, vol. 50, no. 4, pp. 331–335, 2006.
[13] H. Shinomiya, K. Nagai, H. Hirata et al., “Preparation
and characterization of recombinant murine p65/L-plastin
expressed in Escherichia coli and high-titer antibodies against
the protein,” Bioscience, Biotechnology and Biochemistry, vol.
67, no. 6, pp. 1368–1375, 2003.
[14] K. Toyooka, F. Liu, M. Ishii et al., “Generation and charac-
terization of monoclonal antibodies that speciﬁcally recognize
p65/L-plastin isoform but not T-plastin isoform,” Bioscience,
Biotechnology and Biochemistry, vol. 70, no. 6, pp. 1402–1407,
2006.
[15] F. Liu, H. Shinomiya, T. Kirikae, H. Hirata, and Y. Asano,
“Characterization of murine grancalcin speciﬁcally expressed
in leukocytes and its possible role in host defense against bac-
terial infection,” Bioscience, Biotechnology and Biochemistry,
vol. 68, no. 4, pp. 894–902, 2004.
[16] M. Shiroo and K. Matsushima, “Enhanced phosphorylation
of 65 and 74 kDa proteins by tumor necrosis factor and
interleukin-1 in human peripheral blood mononuclear cells,”
Cytokine, vol. 2, no. 1, pp. 13–20, 1990.
[17] J. G. Evans, I. Correia, O. Krasavina, N. Watson, and P.
Matsudaira, “Macrophage podosomes assemble at the leading
lamella by growth and fragmentation,” J o u r n a lo fC e l lB i o l o g y ,
vol. 161, no. 4, pp. 697–705, 2003.
[18] P. Herbomel, B. Thisse, and C. Thisse, “Ontogeny and
behaviour of early macrophages in the zebraﬁsh embryo,”
Development, vol. 126, no. 17, pp. 3735–3745, 1999.
[19] P. Herbomel, B. Thisse, and C. Thisse, “Zebraﬁsh early
macrophages colonize cephalic mesenchyme and developing
brain, retina, and epidermis through a M-CSF receptor-
dependent invasive process,” Developmental Biology, vol. 238,
no. 2, pp. 274–288, 2001.
[20] J. R. Mathias, M. E. Dodd, K. B. Walters, S. K. Yoo,
E. A. Ranheim, and A. Huttenlocher, “Characterization of
zebraﬁsh larval inﬂammatory macrophages,” Developmental
and Comparative Immunology, vol. 33, no. 11, pp. 1212–1217,
2009.
[21] D. H. Zhou, Z. G. Yuan, F. R. Zhao et al., “Modulation of
mouse macrophage proteome induced by Toxoplasma gondii
tachyzoites in vivo,” Parasitology Research, vol. 109, no. 6, pp.
1637–1646, 2011.
[22] M. Shibata, Y. Yamakawa, T. Ohoka, S. Mizuno, and K.
Suzuki, “Characterization of a 64-kd protein phosphorylated
during chemotactic activation with IL-8 and fMLP of human
polymorphonuclear leukocytes. II. Puriﬁcation and amino
acid analysis of phosphorylated 64-kd protein,” Journal of
Leukocyte Biology, vol. 54, no. 1, pp. 10–16, 1993.
[23] S. L. Jones and E. J. Brown, “FcγRII-mediated adhesion
and phagocytosis induce L-plastin phosphorylation in human
neutrophils,” The Journal of Biological Chemistry, vol. 271, no.
24, pp. 14623–14630, 1996.
[24] J. Wang and E. J. Brown, “Immune complex-induced integrin
activation and L-plastin phosphorylation require protein
kinase A,” The Journal of Biological Chemistry, vol. 274, no. 34,
pp. 24349–24356, 1999.
[25] S. L. Jones, J. Wang, C. W. Turck, and E. J. Brown, “A role
for the actin-bundling protein L-plastin in the regulation
of leukocyte integrin function,” Proceedings of the National
Academy of Sciences of the United States of America, vol. 95, no.
16, pp. 9331–9336, 1998.
[26] H. Chen, A. Mocsai, H. Zhang et al., “Role for plastin in host
defensedistinguishesintegrinsignalingfromcelladhesionand
spreading,” Immunity, vol. 19, no. 1, pp. 95–104, 2003.
[27] K. Pazdrak, T. W. Young, C. Straub, S. Staﬀord, and A.
Kurosky, “Priming of eosinophils by GM-CSF is mediated
by protein kinase CbII-phosphorylated L-plastin,” Journal of
Immunology, vol. 186, no. 11, pp. 6485–6496, 2011.
[28] S. G. Babb, P. Matsudaira, M. Sato, I. Correia, and S. S. Lim,
“Fimbrininpodosomesofmonocyte-derivedosteoclasts,”Cell
MotilityandtheCytoskeleton, vol. 37, no. 4, pp. 308–325, 1997.
[29] T. Ma, K. Sadashivaiah, N. Madayiputhiya, and M. A. Chel-
laiah, “Regulation of sealing ring formation by L-plastin and
cortactin in osteoclasts,” The Journal of Biological Chemistry,
vol. 285, no. 39, pp. 29911–29924, 2010.
[30] Y. Zu, K. Shigesada, E. Nishida et al., “65-kilodalton pro-
tein phosphorylated by interleukin 2 stimulation bears two
putative actin-binding sites and two calcium-binding sites,”
Biochemistry, vol. 29, no. 36, pp. 8319–8324, 1990.
[31] S. W. Henning, S. C. Meuer, and Y. Samstag, “Serine phos-
phorylation of a 67-kDa protein in human T lymphocytes
represents an accessory receptor-mediated signaling event,”
Journal of Immunology, vol. 152, no. 10, pp. 4808–4815, 1994.
[32] M. J. Frederick, L. V. Rodriguez, D. A. Johnston, B. G.
Darnay, and E. A. Grimm, “Characterization of the Mr
65,000 lymphokine-activated killer proteins phosphorylated
after tumor target binding: evidence that pp65a and pp65b are
phosphorylated forms of L-plastin,” Cancer Research, vol. 56,
no. 1, pp. 138–144, 1996.
[33] G. H. Wabnitz, T. K¨ ocher, P. Lohneis et al., “Costimulation
induced phosphorylation of L-plastin facilitates surface trans-
port of the T cell activation molecules CD69 and CD25,”
European Journal of Immunology, vol. 37, no. 3, pp. 649–662,
2007.
[34] S. C. Morley, C. Wang, W. L. Lo et al., “The actin-bundling
protein L-plastin dissociates CCR7 proximal signaling from
CCR7-induced motility,” Journal of Immunology, vol. 184, no.
7, pp. 3628–3638, 2010.
[35] G. H. Wabnitz, P. Lohneis, H. Kirchgessner et al., “Sustained
LFA-1 cluster formation in the immune synapse requires the
combined activities of L-plastin and calmodulin,” European
Journal of Immunology, vol. 40, no. 9, pp. 2437–2449, 2010.
[36] W. Chen, S. C. Morley, D. Donermeyer et al., “Actin-
bundling protein L-plastin regulates T cell activation,” Journal
of Immunology, vol. 185, no. 12, pp. 7487–7497, 2010.
[37] E. M. Todd, L. E. Deady, and S. C. Morley, “The actin-
bundling protein L-plastin is essential for marginal zone B
cell development,” Journal of Immunology, vol. 187, no. 6, pp.
3015–3025, 2011.International Journal of Cell Biology 7
[38] C. A. Lunn, E. P. Reich, J. S. Fine et al., “Biology and therapeu-
tic potential of cannabinoid CB2 receptor inverse agonists,”
British Journal of Pharmacology, vol. 153, no. 2, pp. 226–239,
2008.
[39] G. H. Wabnitz, F. Michalke, C. Stober et al., “L-plastin
phosphorylation: a novel target for the immunosuppressive
drug dexamethasone in primary human T-cells,” European
Journal of Immunology, vol. 41, no. 11, pp. 3157–3169, 2011.
[40] B. Janji, A. Giganti, V. De Corte et al., “Phosphorylation on
Ser5 increases the F-actin-binding activity of L-plastin and
promotes its targeting to sites of actin assembly in cells,”
Journal of Cell Science, vol. 119, no. 9, pp. 1947–1960, 2006.
[41] G. E. Oprea, S. Kr¨ ober, M. L. McWhorter et al., “Plastin 3 is
a protective modiﬁer of autosomal recessive spinal muscular
atrophy,” Science, vol. 320, no. 5875, pp. 524–527, 2008.
[42] M. Ralser, U. Nonhoﬀ, M. Albrecht et al., “Ataxin-2 and
huntingtin interact with endophilin-A complexes to function
in plastin-associated pathways,” Human Molecular Genetics,
vol. 14, no. 19, pp. 2893–2909, 2005.
[43] M. Bowerman, C. L. Anderson, A. Beauvais, P. P. Boyl, W.
Witke, and R. Kothary, “SMN, proﬁlin IIa and plastin 3: a
link between the deregulation of actin dynamics and SMA
pathogenesis,”MolecularandCellularNeuroscience,vol.42,no.
1, pp. 66–74, 2009.
[44] D. Drenckhahn, K. Engel, D. Hofer, C. Merte, L. Tilney, and
M. Tilney, “Three diﬀerent actin ﬁlament assemblies occur
in every hair cell: each contains a speciﬁc actin crosslinking
protein,” J o u r n a lo fC e l lB i o l o g y , vol. 112, no. 4, pp. 641–651,
1991.
[45] K. H. Lee and D. A. Cotanche, “Localization of the hair-cell-
speciﬁc protein ﬁmbrin during regeneration in the chicken
cochlea,” Audiology and Neuro-Otology, vol. 1, no. 1, pp. 41–
53, 1996.
[46] P. Lawlor, W. Marcotti, M. N. Rivolta, C. J. Kros, and M.
C. Holley, “Diﬀerentiation of mammalian vestibular hair
cells from conditionally immortal, postnatal supporting cells,”
Journal of Neuroscience, vol. 19, no. 21, pp. 9445–9458, 1999.
[47] N. Daudet and M. C. Lebart, “Transient expression of the
T-isoform of plastins/ﬁmbrin in the stereocilia of developing
auditory hair cells,” Cell Motility and the Cytoskeleton, vol. 53,
no. 4, pp. 326–336, 2002.
[48] A. Bretscher and K. Weber, “Fimbrin, a new microﬁlament-
associated protein present in microvilli and other cell surface
structures,” Journal of Cell Biology, vol. 86, no. 1, pp. 335–340,
1980.
[49] A. Bretscher, “Puriﬁcation of an 80,000-dalton protein that is
a component of the isolated microvillus cytoskeleton, and its
localizationinnonmusclecells,”J ournalofC ellBiology,vol.97,
no. 2, pp. 425–432, 1983.
[50] M. B. Heintzelman and M. S. Mooseker, “Assembly of the
brush border cytoskeleton: changes in the distribution of
microvillar core proteins during enterocyte diﬀerentiation in
adult chicken intestine,” CellMotilityandtheCytoskeleton, vol.
15, no. 1, pp. 12–22, 1990.
[51] C. S. Lin, W. Shen, Z. P. Chen, Y. H. Tu, and P. Matsu-
daira, “Identiﬁcation of I-plastin, a human ﬁmbrin isoform
expressed in intestine and kidney,” Molecular and Cellular
Biology, vol. 14, no. 4, pp. 2457–2467, 1994.
[52] E. M. S. Grimm-G¨ unter, C. Revenu, S. Ramos et al., “Plastin
1 binds to keratin and is required for terminal web assembly
in the intestinal epithelium,” Molecular Biology of the Cell, vol.
20, no. 10, pp. 2549–2562, 2009.
[53] J. W. Brown and C. J. McKnight, “Molecular model of
the microvillar cytoskeleton and organization of the brush
border,” PLoS ONE, vol. 5, no. 2, Article ID e9406, 2010.
[54] C. S. Lin, T. Park, Z. P. Chen, and J. Leavitt, “Human plastin
genes. Comparative gene structure, chromosome location,
anddiﬀerentialexpressioninnormalandneoplasticcells,”The
Journal of Biological Chemistry, vol. 268, no. 4, pp. 2781–2792,
1993.
[55] C. S. Lin, Z. P. Chen, T. Park, K. Ghosh, and J. Leavitt,
“Characterization of the human L-plastin gene promoter
in normal and neoplastic cells,” The Journal of Biological
Chemistry, vol. 268, no. 4, pp. 2793–2801, 1993.
[ 5 6 ] T .P a r k ,Z .P .C h e n ,a n dJ .L e a v i t t ,“ A c t i v a t i o no ft h el e u k o c y t e
plastin gene occurs in most human cancer cells,” Cancer
Research, vol. 54, no. 7, pp. 1775–1781, 1994.
[57] C. S. Lin, A. Lau, C. C. Yeh, C. H. Chang, and T. F. Lue,
“Upregulation of L-plastin gene by testosterone in breast
and prostate cancer cells: identiﬁcation of three cooperative
androgen receptor-binding sequences,” DNA and Cell Biology,
vol. 19, no. 1, pp. 1–7, 2000.
[58] J. Leavitt, Z. P. Chen, C. J. Lockwood, and F. Schatz, “Reg-
ulation of synthesis of the transformation-induced protein,
leukocyte plastin, by ovarian steroid hormones,” Cancer
Research, vol. 54, no. 13, pp. 3447–3454, 1994.
[59] J. Zheng, N. Rudra-Ganguly, G. J. Miller, K. A. Moﬀatt, R. J.
Cote, and P. Roy-Burman, “Steroid hormone induction and
expression patterns of L-plastin in normal and carcinomatous
prostate tissues,” American Journal of Pathology, vol. 150, no.
6, pp. 2009–2018, 1997.
[60] S. Gali` egue-Zouitina, S. Quief, M. P. Hildebrand et al.,
“Nonrandom fusion of L-plastin(LCP1) and LAZ3(BCL6)
genes by t(3;13)(q27;q14) chromosome translocation in two
cases of B-cell non-Hodgkin lymphoma,” Genes Chromosomes
and Cancer, vol. 26, no. 2, pp. 97–105, 1999.
[61] A. Lapillonne, O. Cou´ e, E. Friederich et al., “Expression
patterns of L-plastin isoform in normal and carcinomatous
breast tissues,” Anticancer Research, vol. 20, no. 5, pp. 3177–
3182, 2000.
[62] M. Otsuka, M. Kato, T. Yoshikawa et al., “Diﬀerential expres-
sion of the L-plastin gene in human colorectal cancer pro-
gression and metastasis,” Biochemical and Biophysical Research
Communications, vol. 289, no. 4, pp. 876–881, 2001.
[ 6 3 ]E .F o r a n ,P .M c W i l l i a m ,D .K e l l e h e r ,D .T .C r o k e ,a n dA .
Long, “The leukocyte protein L-plastin induces proliferation,
invasion and loss of E-cadherin expression in colon cancer
cells,”InternationalJournalofCancer,vol.118,no.8,pp.2098–
2104, 2006.
[ 6 4 ]M .K l e m k e ,M .T .R a f a e l ,G .H .W a b n i t ze ta l . ,“ P h o s p h o r y l a -
tionofectopicallyexpressedL-plastinenhancesinvasivenessof
human melanoma cells,” International Journal of Cancer, vol.
120, no. 12, pp. 2590–2599, 2007.
[65] Y. Sasaki, F. Itoh, T. Kobayashi et al., “Increased expression
of T-ﬁmbrin gene after DNA damage in CHO cells and
inactivation of T-ﬁmbrin by CPG methylation in human
colorectalcancercells,”InternationalJournalofCancer,vol.97,
no. 2, pp. 211–216, 2002.
[66] L. Kari, A. Loboda, M. Nebozhyn et al., “Classiﬁcation and
prediction of survival in patients with the leukemic phase
of cutaneous T cell lymphoma,” Journal of Experimental
Medicine, vol. 197, no. 11, pp. 1477–1488, 2003.
[67] E. Capriotti, E. C. Vonderheid, C. J. Thoburn, M. Wasik, D.
W. Bahler, and A. D. Hess, “Expression of T-plastin, FoxP38 International Journal of Cell Biology
and other tumor-associated markers by leukemic T-cells of
cutaneous T-cell lymphoma,” Leukemia and Lymphoma, vol.
49, no. 6, pp. 1190–1201, 2008.
[68] M. W. Su, I. Dorocicz, W. H. Dragowska et al., “Aberrant
expression of T-plastin in sezary cells,” Cancer Research, vol.
63, no. 21, pp. 7122–7127, 2003.
[69] N. Tang, H. Gibson, T. Germeroth, P. Porcu, H. W. Lim, and
H. K. Wong, “T-plastin (PLS3) gene expression diﬀerentiates
S´ ezary syndrome from mycosis fungoides and inﬂammatory
skin diseases and can serve as a biomarker to monitor disease
progression,” British Journal of Dermatology, vol. 162, no. 2,
pp. 463–466, 2010.
[70] R. Hussain and A. Bajoghli, “Primary cutaneous CD30-
positive large T cell lymphoma in an 80-year-old man: a case
report,” ISRN Dermatology, vol. 2011, Article ID 634042, pp.
1–3, 2011.
[71] M. Hasselblatt, C. B¨ ohm, L. Tatenhorst et al., “Identiﬁcation
of novel diagnostic markers for choroid plexus tumors: a
microarray-based approach,” American Journal of Surgical
Pathology, vol. 30, no. 1, pp. 66–74, 2006.
[72] L. D. Harris, J. De La Cerda, T. Tuziak et al., “Analysis of the
expression of biomarkers in urinary bladder cancer using a
tissue microarray,” Molecular Carcinogenesis,v o l .4 7 ,n o .9 ,p p .
678–685, 2008.
[ 7 3 ]S .K a n g ,H .S .S h i m ,J .S .L e ee ta l . ,“ M o l e c u l a rp r o t e o m i c s
imaging of tumor interfaces by mass spectrometry,” Journal of
Proteome Research, vol. 9, no. 2, pp. 1157–1164, 2010.
[74] C. S. Ang and E. C. Nice, “Targeted in-gel MRM: a hypothesis
driven approach for colorectal cancer biomarker discovery in
human feces,” Journal of Proteome Research, vol. 9, no. 9, pp.
4346–4355, 2010.
[75] I. Chung, P. E. Schwartz, R. G. Crystal, G. Pizzorno, J. Leavitt,
andA.B.Deisseroth,“UseofL-plastinpromotertodevelopan
adenoviralsystemthatconferstransgeneexpressioninovarian
cancer cells but not in normal mesothelial cells,” Cancer Gene
Therapy, vol. 6, no. 2, pp. 99–106, 1999.
[76] X. Y. Peng, J. H. Won, T. Rutherford et al., “The use of the
L-plastin promoter for adenoviral-mediated, tumor-speciﬁc
gene expression in ovarian and bladder cancer cell lines,”
Cancer Research, vol. 61, no. 11, pp. 4405–4413, 2001.
[77] H. Akbulut, L. Zhang, Y. Tang, and A. Deisseroth, “Cytotoxic
eﬀect of replication-competent adenoviral vectors carrying
L-plastin promoter regulated E1A and cytosine deaminase
genes in cancers of the breast, ovary and colon,” Cancer Gene
Therapy, vol. 10, no. 5, pp. 388–395, 2003.
[78] J. Zheng, N. Rudra-Ganguly, W. C. Powell, and P. Roy-
Burman, “Suppression of prostate carcinoma cell invasion by
expression of antisense L-plastin gene,” American Journal of
Pathology, vol. 155, no. 1, pp. 115–122, 1999.